Swetha Anandhan

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Venues

Nature communications

Nature cancer

Science translational medicine

Nature reviews. Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Swetha Anandhan, Shelley Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Daniel Macaluso, Sonali Jindal, Seanu Meena Natarajan, Samuel W Andrewes, Liangwen Xiong, Ashwat Nagarajan, Sreyashi Basu, Derek Ng Tang, Jielin Liu, Jimin Min, Anirban Maitra, Padmanee Sharma
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature communications 15 (1) (2024)
Swetha Anandhan, Shelley Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Daniel Macaluso, Sonali Jindal, Seanu Meena Natarajan, Samuel W Andrewes, Liangwen Xiong, Ashwat Nagarajan, Sreyashi Basu, Derek Ng Tang, Jielin Liu, Jimin Min, Anirban Maitra, Padmanee Sharma
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature communications 15 (1) (2024)
Swetha Anandhan, Shelley Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Daniel Macaluso, Sonali Jindal, Seanu Meena Natarajan, Samuel W Andrewes, Liangwen Xiong, Ashwat Nagarajan, Sreyashi Basu, Derek Ng Tang, Jielin Liu, Jimin Min, Anirban Maitra, Padmanee Sharma
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature communications 15 (1) (2024)
Swetha Anandhan, Shelley Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Daniel Macaluso, Sonali Jindal, Seanu Meena Natarajan, Samuel W Andrewes, Liangwen Xiong, Ashwat Nagarajan, Sreyashi Basu, Derek Ng Tang, Jielin Liu, Jimin Min, Anirban Maitra, Padmanee Sharma
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature communications 15 (1) (2024)
Sangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, Seanu Meena Natarajan, Yulong Chen, Candice Poon, Mercedes Hennessey, Aminah J Tannir, Jan Zhang, Swetha Anandhan, Brittany Parker Kerrigan, Marc D Macaluso, Zhong He, Sonali Jindal, Frederick F Lang, Sreyashi Basu, Padmanee Sharma
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade. Nature cancer (2023)
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, Padmanee Sharma
Myeloid cell-targeted therapies for solid tumours. Nature reviews. Immunology (2022)
Padmanee Sharma, Bilal A Siddiqui, Swetha Anandhan, Shalini Singh Yadav, Sumit K Subudhi, Jianjun Gao, Sangeeta Goswami, James P Allison
The Next Decade of Immune Checkpoint Therapy. Cancer discovery 11 (4) (2022)
Sangeeta Goswami, Yulong Chen, Swetha Anandhan, Peter M Szabo, Sreyashi Basu, Jorge M Blando, Wenbin Liu, Jan Zhang, Seanu Meena Natarajan, Liangwen Xiong, Baoxiang Guan, Shalini Singh Yadav, Abdel Saci, James P Allison, Matthew D Galsky, Padmanee Sharma
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC. Science translational medicine 12 (548) (2021)

Swetha Anandhan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Swetha Anandhan